Cargando…
Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
Extensive damage to nigrostriatal dopaminergic neurons leads to Parkinson’s disease (PD). To date, the most effective treatment has been administration of levodopa (L-DOPA) to increase dopaminergic tone. This treatment leads to responses that vary widely among patients, from predominantly beneficial...
Autores principales: | Albarrán-Bravo, Sacnité, Ávalos-Fuentes, José Arturo, Cortés, Hernán, Rodriguez-Sánchez, Marina, Leyva-García, Norberto, Rangel-Barajas, Claudia, Erlij, David, Florán, Benjamín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770442/ https://www.ncbi.nlm.nih.gov/pubmed/31480516 http://dx.doi.org/10.3390/biom9090431 |
Ejemplares similares
-
Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
por: Du, Huan, et al.
Publicado: (2015) -
Serotonergic system modulation holds promise for L-DOPA-induced dyskinesias in hemiparkinsonian rats: A systematic review
por: Farajdokht, Fereshteh, et al.
Publicado: (2020) -
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model
por: dos Santos Pereira, Maurício, et al.
Publicado: (2022) -
Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats
por: Padovan-Neto, Fernando Eduardo, et al.
Publicado: (2011) -
Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA
por: Rodríguez-Sánchez, Marina, et al.
Publicado: (2019)